The findings mentioned above, i.e., the upregulation of PHOX2A and CDH2 accompanied by a decrease in the expression of HTATIP2 in MM compared with MGUS, are consistent with the trends observed in the methylation and miRNA analyses. The gene discussed is HTATIP2; the disease is Miyoshi myopathy.